Hagen Kulbe
7PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 28, 2023
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients.Wanja Kassuhn, Pedro R Cutillas, Mirjana Kessler
|Oct 14, 2022
Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer.Jana Ihlow, Nanna Monjé, Inga Hoffmann
|Jan 11, 2022
Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring.Elena Ioana Braicu, Andreas du Bois, Jalid Sehouli
|Apr 30, 2021
A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer.Liina Salminen, Elena Ioana Braicu, Mitja Lääperi
|Apr 03, 2021
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.Wanja Kassuhn, Oliver Klein, Silvia Darb-Esfahani
|Jul 26, 2020
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging.Hagen Kulbe, Oliver Klein, Zhiyang Wu
Pageof 2
Frequent Collaborators
2 joint publications
Wolfgang Daniel Schmitt
2 joint publications
Jalid Sehouli
2 joint publications
Philipp Harter
1 joint publications
Raik Otto
1 joint publications
Reinhold Schäfer
1 joint publications
Wanja Kassuhn
1 joint publications
Paul Jank
1 joint publications
Carlotta Keunecke
1 joint publications
Joshy George
1 joint publications
Nils Blüthgen
